Description
Molnupiravir 200 mg Capsule
Oral antiviral treatment for mild to moderate COVID-19 in adults
Product Description
Molnupiravir 200 mg is an oral antiviral medication designed to treat mild to moderate COVID-19 in adults at high risk of developing severe illness. It works by inhibiting the replication of the SARS-CoV-2 virus, thereby reducing viral load and disease progression.
This prescription medication should be started within 5 days of symptom onset for maximum effectiveness.
Benefits
- Reduces risk of hospitalization and severe disease
- Oral capsule – easy to take without injections
- Short treatment course (5 days)
- Effective against multiple COVID-19 variants
Dosage & Administration
- Recommended dose: 800 mg (4 capsules) twice daily for 5 days
- Start treatment within 5 days of symptom onset
- Take with or without food
- Complete the full prescribed course
Precautions & Warnings
- Not recommended for pregnant or breastfeeding women
- Use effective contraception during and after treatment
- Not approved for use in children under 18 years
- Consult a healthcare provider if you have liver or kidney disease
Frequently Asked Questions (FAQs)
1. What is Molnupiravir used for?
It is used to treat mild to moderate COVID-19 in adults at high risk of developing severe illness.
2. How soon should I start the treatment?
Molnupiravir should be started within 5 days of the first symptoms of COVID-19.
3. Can I take Molnupiravir if I am pregnant?
No, Molnupiravir is not recommended during pregnancy or breastfeeding.
4. Are there any side effects?
Common side effects may include nausea, headache, and diarrhea. Consult your doctor if you experience severe side effects.
5. Do I need a prescription to buy Molnupiravir?
Yes, Molnupiravir is a prescription-only medicine and should be used under medical supervision.